24/11/2022.
Skin cancer is the most common cancer in the world. It is is deadly at late stage but can be cured with high survival rate if being detected early.
21/11/2022.
iToBoS representatives attended the presentation of the technological report on the Digital Health ecosystem in Catalonia, carried out by ACCIÓ (Agència per la Competitivitat de l’Empresa) with the support of Biocat. The event was held in Catalan.
20/11/2022.
More than 33 participants gathered in Brussels on 18-20 November for the MPNE mini-Meet 2022, held under a new Over the Edge format.
20/11/2022.
iToBoS was presented at the 86th Annual Meeting of the Tokyo Division of JDA, an online event.
18/11/2022.
In the past decades, there have been developments in computational methods for helping dermatologists diagnose skin cancer early. Computerized analysis of pigmented skin lesions (PSLs) is a growing field of research.
17/11/2022.
iToBoS representatives attended the Smart City Expo World Congress, which took place in Barcelona from November 15 to 17, 2022.
14/11/2022.
Validation of medical devices is concerned with the end product and – according to a FDA’s definition - it intends “to check that the device / system and its specifications conform with the user needs and the intended use(s)”
11/11/2022.
As already mentioned, medical device verification is often done at sub-system / module level and often in parallel with the design and development phases. It requires the availability of the specifications and of testing procedures / methods.
9/11/2022.
Even if the two terms are often used interchangeably, they refer to two different types of analysis.
8/11/2022.
The RSA conference is one of the top industry security conferences in the world, offering four days of nonstop cutting-edge sessions, inspirational keynotes, and groundbreaking innovation.